Please use this identifier to cite or link to this item: http://doi.org/10.25358/openscience-5217
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRezapour, Jasmin-
dc.contributor.authorSchuster, Alexander K.-
dc.contributor.authorNickels, Stefan-
dc.contributor.authorKorb, Christina A.-
dc.contributor.authorElbaz, Hisham-
dc.contributor.authorPeto, Tunde-
dc.contributor.authorMichal, Matthias-
dc.contributor.authorMünzel, Thomas-
dc.contributor.authorWild, Philipp S.-
dc.contributor.authorKönig, Jochem-
dc.contributor.authorLackner, Karl-
dc.contributor.authorSchulz, Andreas-
dc.contributor.authorPfeiffer, Norbert-
dc.contributor.authorBeutel, Manfred E.-
dc.date.accessioned2020-10-26T09:02:44Z-
dc.date.available2020-10-26T09:02:44Z-
dc.date.issued2020-
dc.identifier.urihttps://openscience.ub.uni-mainz.de/handle/20.500.12030/5221-
dc.description.abstractTo investigate the prevalence and new onset of depression and anxiety among subjects with agerelated macular degeneration (AMD) and its association with AMD in a large European cohort with relatively good visual acuity. 11,834 participants enrolled in the German population-based Gutenberg Health Study were studied. AMD was diagnosed by grading of fundus photographs. Depression and anxiety were assessed with the Patient Health Questionnaire and the Generalized Anxiety Disorder-2 Scale, respectively. Logistic regression analyses were performed and adjusted for several parameters. 1,089 (9.2%) participants were diagnosed having AMD. Prevalence of depression in AMD and non-AMD participants was 7.2% and 8.0%, respectively and prevalence of anxiety was 4.2% and 7.0%, respectively. New onset of depression and anxiety at 5-year follow-up in AMD subjects was 2.6% and 3.6%, respectively. AMD was not associated with depression (OR 0.93; CI 95% 0.70–1.20; p = 0.62). AMD was associated with less anxiety (OR 0.67; CI 95% 0.47–0.93; p = 0.02). This is the first study analyzing both prevalence and new onset of depression and anxiety in AMD subjects. AMD- and non-AMD participants had a similar prevalence and new onset of depression in our population-based sample. Participants without AMD had a higher prevalence of anxiety. AMD was not associated with depression.en_GB
dc.description.sponsorshipDFG, Open Access-Publizieren Universität Mainz / Universitätsmedizinde
dc.language.isoengde
dc.rightsCC BY-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subject.ddc610 Medizinde_DE
dc.subject.ddc610 Medical sciencesen_GB
dc.titlePrevalence and new onset of depression and anxiety among participants with AMD in a European cohorten_GB
dc.typeZeitschriftenaufsatzde
dc.identifier.doihttp://doi.org/10.25358/openscience-5217-
jgu.type.contenttypeScientific articlede
jgu.type.dinitypearticleen_GB
jgu.type.versionPublished versionde
jgu.type.resourceTextde
jgu.organisation.departmentFB 04 Medizinde
jgu.organisation.number2700-
jgu.organisation.nameJohannes Gutenberg-Universität Mainz-
jgu.rights.accessrightsopenAccess-
jgu.journal.titleScientific Reportsde
jgu.journal.volume10de
jgu.pages.alternativeArt. 4816de
jgu.publisher.year2020-
jgu.publisher.nameMacmillan Publishers Limited, part of Springer Naturede
jgu.publisher.placeLondonde
jgu.publisher.urihttps://doi.org/10.1038/s41598-020-61706-8de
jgu.publisher.issn2045-2322de
jgu.organisation.placeMainz-
jgu.subject.ddccode610de
jgu.publisher.doi10.1038/s41598-020-61706-8
jgu.organisation.rorhttps://ror.org/023b0x485
Appears in collections:JGU-Publikationen

Files in This Item:
  File Description SizeFormat
Thumbnail
rezapour_jasmin-prevalence_and-20201016123926059.pdf1.25 MBAdobe PDFView/Open